Apixaban inhibits cerebral microembolic signals derived from carotid arterial thrombosis in rabbits

4Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

Cerebral microembolic signal (MES) is an independent predictor of stroke risk and prognosis. The objective of this study is to assess the effects of apixaban, as a representative of the novel oral anticoagulant class, on a rabbit model of cerebral MES. A clinical transcranial Doppler ultrasound instrument was used to assess MESs in the middle cerebral artery in a 30% FeCl3- induced carotid arterial thrombosis model in male New Zealand White rabbits. Ascending doses of apixaban were evaluated as monotherapy and in combination with aspirin on both arterial thrombosis and MES. Pharmacokinetic and pharmacodynamic responses were also evaluated. The effective dose for 50% inhibition (ED50) of thrombus formation for monotherapy was 0.04 mg/kg per hour apixaban, i.v. (0.03 mM plasma exposure) for the integrated blood flow, 0.13 mg/kg per hour apixaban (0.10 mM plasma exposure) for thrombus weight, and 0.03 mg/kg per hour apixaban (0.02 mM plasma exposure) for MES. Dual treatment with aspirin (5 mg/kg, PO) and apixaban (0.015 mg/kg per hour, i.v.) resulted in a significant reduction in cerebral MES (P , 0.05) compared with monotherapy with either agent. Pharmacokinetic analysis of apixaban and pharmacodynamic assays using activated partial thromboplastin time (aPTT) and prothrombin time (PT) for apixaban- And arachidonic acidinduced platelet aggregation for aspirin were used to confirm the exposure-response relationships. In summary, our study demonstrates that apixaban in a concentration-dependent manner inhibits both arterial thrombosis and MES, suggesting a potential association between factor Xa (FXa) blockade and the reduction in MES in patients at risk of ischemic stroke.

References Powered by Scopus

Apixaban versus warfarin in patients with atrial fibrillation

7737Citations
N/AReaders
Get full text

Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: The clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis (CARESS) trial

702Citations
N/AReaders
Get full text

Consensus on microembolus detection by TCD: International consensus group on microembolus detection

584Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Factor XIIa as a novel target for thrombosis: Target engagement requirement and efficacy in a rabbit model of microembolic signals

14Citations
N/AReaders
Get full text

Inhibition of factor Xia reduces the frequency of cerebral Microembolic signals derived from carotid arterial thrombosis in Rabbits

7Citations
N/AReaders
Get full text

Transcranial Doppler findings in antiphospholipid syndrome

4Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Zhou, X., Wu, W., Chu, L., Gutstein, D. E., Seiffert, D., & Wang, X. (2016). Apixaban inhibits cerebral microembolic signals derived from carotid arterial thrombosis in rabbits. Journal of Pharmacology and Experimental Therapeutics, 358(3), 405–412. https://doi.org/10.1124/jpet.116.234575

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

88%

Researcher 1

13%

Readers' Discipline

Tooltip

Medicine and Dentistry 6

55%

Pharmacology, Toxicology and Pharmaceut... 3

27%

Chemistry 1

9%

Nursing and Health Professions 1

9%

Save time finding and organizing research with Mendeley

Sign up for free